iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control Article Swipe
Mario Castro
,
Merrill J. Zavod
,
Annika Rutgersson
,
Magnus Jörntén‐Karlsson
,
Bhaskar Dutta
,
Lynn Hagger
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2147/jaa.s458618
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.2147/jaa.s458618
These findings emphasize the need to systematically compare devices based on several parameters, including usability and data quality, to develop integrated digital technology programs for asthma care.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.2147/jaa.s458618
- https://www.dovepress.com/article/download/94165
- OA Status
- gold
- Cited By
- 1
- References
- 42
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4400512535
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4400512535Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.2147/jaa.s458618Digital Object Identifier
- Title
-
iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease ControlWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-07-01Full publication date if available
- Authors
-
Mario Castro, Merrill J. Zavod, Annika Rutgersson, Magnus Jörntén‐Karlsson, Bhaskar Dutta, Lynn HaggerList of authors in order
- Landing page
-
https://doi.org/10.2147/jaa.s458618Publisher landing page
- PDF URL
-
https://www.dovepress.com/article/download/94165Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.dovepress.com/article/download/94165Direct OA link when available
- Concepts
-
Medicine, Selection (genetic algorithm), Asthma, Disease, Disease control, Control (management), Intensive care medicine, Artificial intelligence, Internal medicine, Environmental health, Computer scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
42Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4400512535 |
|---|---|
| doi | https://doi.org/10.2147/jaa.s458618 |
| ids.doi | https://doi.org/10.2147/jaa.s458618 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/39011068 |
| ids.openalex | https://openalex.org/W4400512535 |
| fwci | 0.7563153 |
| type | article |
| title | iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control |
| biblio.issue | |
| biblio.volume | Volume 17 |
| biblio.last_page | 666 |
| biblio.first_page | 653 |
| topics[0].id | https://openalex.org/T10051 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9948999881744385 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Asthma and respiratory diseases |
| topics[1].id | https://openalex.org/T11446 |
| topics[1].field.id | https://openalex.org/fields/36 |
| topics[1].field.display_name | Health Professions |
| topics[1].score | 0.9836999773979187 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3600 |
| topics[1].subfield.display_name | General Health Professions |
| topics[1].display_name | Mobile Health and mHealth Applications |
| topics[2].id | https://openalex.org/T11519 |
| topics[2].field.id | https://openalex.org/fields/32 |
| topics[2].field.display_name | Psychology |
| topics[2].score | 0.9659000039100647 |
| topics[2].domain.id | https://openalex.org/domains/2 |
| topics[2].domain.display_name | Social Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/3202 |
| topics[2].subfield.display_name | Applied Psychology |
| topics[2].display_name | Digital Mental Health Interventions |
| is_xpac | False |
| apc_list.value | 2836 |
| apc_list.currency | USD |
| apc_list.value_usd | 2836 |
| apc_paid.value | 2836 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 2836 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9347177147865295 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C81917197 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6531767845153809 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q628760 |
| concepts[1].display_name | Selection (genetic algorithm) |
| concepts[2].id | https://openalex.org/C2776042228 |
| concepts[2].level | 2 |
| concepts[2].score | 0.6415802240371704 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q35869 |
| concepts[2].display_name | Asthma |
| concepts[3].id | https://openalex.org/C2779134260 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5247856974601746 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[3].display_name | Disease |
| concepts[4].id | https://openalex.org/C2987315675 |
| concepts[4].level | 2 |
| concepts[4].score | 0.44402769207954407 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1773974 |
| concepts[4].display_name | Disease control |
| concepts[5].id | https://openalex.org/C2775924081 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4400913715362549 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q55608371 |
| concepts[5].display_name | Control (management) |
| concepts[6].id | https://openalex.org/C177713679 |
| concepts[6].level | 1 |
| concepts[6].score | 0.33383631706237793 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[6].display_name | Intensive care medicine |
| concepts[7].id | https://openalex.org/C154945302 |
| concepts[7].level | 1 |
| concepts[7].score | 0.26717042922973633 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11660 |
| concepts[7].display_name | Artificial intelligence |
| concepts[8].id | https://openalex.org/C126322002 |
| concepts[8].level | 1 |
| concepts[8].score | 0.18500006198883057 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[8].display_name | Internal medicine |
| concepts[9].id | https://openalex.org/C99454951 |
| concepts[9].level | 1 |
| concepts[9].score | 0.10030975937843323 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q932068 |
| concepts[9].display_name | Environmental health |
| concepts[10].id | https://openalex.org/C41008148 |
| concepts[10].level | 0 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[10].display_name | Computer science |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9347177147865295 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/selection |
| keywords[1].score | 0.6531767845153809 |
| keywords[1].display_name | Selection (genetic algorithm) |
| keywords[2].id | https://openalex.org/keywords/asthma |
| keywords[2].score | 0.6415802240371704 |
| keywords[2].display_name | Asthma |
| keywords[3].id | https://openalex.org/keywords/disease |
| keywords[3].score | 0.5247856974601746 |
| keywords[3].display_name | Disease |
| keywords[4].id | https://openalex.org/keywords/disease-control |
| keywords[4].score | 0.44402769207954407 |
| keywords[4].display_name | Disease control |
| keywords[5].id | https://openalex.org/keywords/control |
| keywords[5].score | 0.4400913715362549 |
| keywords[5].display_name | Control (management) |
| keywords[6].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[6].score | 0.33383631706237793 |
| keywords[6].display_name | Intensive care medicine |
| keywords[7].id | https://openalex.org/keywords/artificial-intelligence |
| keywords[7].score | 0.26717042922973633 |
| keywords[7].display_name | Artificial intelligence |
| keywords[8].id | https://openalex.org/keywords/internal-medicine |
| keywords[8].score | 0.18500006198883057 |
| keywords[8].display_name | Internal medicine |
| keywords[9].id | https://openalex.org/keywords/environmental-health |
| keywords[9].score | 0.10030975937843323 |
| keywords[9].display_name | Environmental health |
| language | en |
| locations[0].id | doi:10.2147/jaa.s458618 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S164068349 |
| locations[0].source.issn | 1178-6965 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1178-6965 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Journal of Asthma and Allergy |
| locations[0].source.host_organization | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_name | Dove Medical Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320348 |
| locations[0].source.host_organization_lineage_names | Dove Medical Press |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | https://www.dovepress.com/article/download/94165 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Asthma and Allergy |
| locations[0].landing_page_url | https://doi.org/10.2147/jaa.s458618 |
| locations[1].id | pmid:39011068 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of asthma and allergy |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/39011068 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11247342 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Asthma Allergy |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11247342 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5029849168 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-6328-8994 |
| authorships[0].author.display_name | Mario Castro |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I146416000 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA |
| authorships[0].institutions[0].id | https://openalex.org/I146416000 |
| authorships[0].institutions[0].ror | https://ror.org/001tmjg57 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I146416000 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | University of Kansas |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Mario Castro |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas School of Medicine, Kansas City, KS, USA |
| authorships[1].author.id | https://openalex.org/A5042066314 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Merrill J. Zavod |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[1].affiliations[0].raw_affiliation_string | User Experience, AstraZeneca, Wilmington, DE, USA |
| authorships[1].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[1].institutions[0].ror | https://ror.org/043cec594 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | AstraZeneca (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Merrill Zavod |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | User Experience, AstraZeneca, Wilmington, DE, USA |
| authorships[2].author.id | https://openalex.org/A5016749982 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Annika Rutgersson |
| authorships[2].countries | SE |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210143795 |
| authorships[2].affiliations[0].raw_affiliation_string | Digital Patient Products, AstraZeneca, Gothenburg, Mölndal, Sweden |
| authorships[2].institutions[0].id | https://openalex.org/I4210143795 |
| authorships[2].institutions[0].ror | https://ror.org/04wwrrg31 |
| authorships[2].institutions[0].type | company |
| authorships[2].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210143795 |
| authorships[2].institutions[0].country_code | SE |
| authorships[2].institutions[0].display_name | AstraZeneca (Sweden) |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Annika Rutgersson |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Digital Patient Products, AstraZeneca, Gothenburg, Mölndal, Sweden |
| authorships[3].author.id | https://openalex.org/A5019986003 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7774-9162 |
| authorships[3].author.display_name | Magnus Jörntén‐Karlsson |
| authorships[3].countries | SE |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210143795 |
| authorships[3].affiliations[0].raw_affiliation_string | Digital Implementation, Digital Health R&D, AstraZeneca, Gothenburg, Mölndal, Sweden |
| authorships[3].institutions[0].id | https://openalex.org/I4210143795 |
| authorships[3].institutions[0].ror | https://ror.org/04wwrrg31 |
| authorships[3].institutions[0].type | company |
| authorships[3].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210143795 |
| authorships[3].institutions[0].country_code | SE |
| authorships[3].institutions[0].display_name | AstraZeneca (Sweden) |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Magnus Jörntén-Karlsson |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Digital Implementation, Digital Health R&D, AstraZeneca, Gothenburg, Mölndal, Sweden |
| authorships[4].author.id | https://openalex.org/A5102883403 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-4352-5419 |
| authorships[4].author.display_name | Bhaskar Dutta |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210125492, https://openalex.org/I4210150756 |
| authorships[4].affiliations[0].raw_affiliation_string | Global Medical Affairs, Alexion, AstraZeneca, Boston, MA, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210125492 |
| authorships[4].institutions[0].ror | https://ror.org/031ywxc85 |
| authorships[4].institutions[0].type | company |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210125492 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Alexion Pharmaceuticals (United States) |
| authorships[4].institutions[1].id | https://openalex.org/I4210150756 |
| authorships[4].institutions[1].ror | https://ror.org/043cec594 |
| authorships[4].institutions[1].type | company |
| authorships[4].institutions[1].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | AstraZeneca (United States) |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Bhaskar Dutta |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Global Medical Affairs, Alexion, AstraZeneca, Boston, MA, USA |
| authorships[5].author.id | https://openalex.org/A5113315600 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Lynn Hagger |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210150756 |
| authorships[5].affiliations[0].raw_affiliation_string | Content Strategy & Experience Design, Digital Global Commercial, AstraZeneca, Gaithersburg, MD, USA |
| authorships[5].institutions[0].id | https://openalex.org/I4210150756 |
| authorships[5].institutions[0].ror | https://ror.org/043cec594 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I105036370, https://openalex.org/I4210150756 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | AstraZeneca (United States) |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Lynn Hagger |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Content Strategy & Experience Design, Digital Global Commercial, AstraZeneca, Gaithersburg, MD, USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.dovepress.com/article/download/94165 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | iPREDICT: Characterization of Asthma Triggers and Selection of Digital Technology to Predict Changes in Disease Control |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10051 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9948999881744385 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Asthma and respiratory diseases |
| related_works | https://openalex.org/W2196358948, https://openalex.org/W1075988649, https://openalex.org/W4382298417, https://openalex.org/W2763069634, https://openalex.org/W2395336337, https://openalex.org/W2035331892, https://openalex.org/W1524220139, https://openalex.org/W2792401660, https://openalex.org/W2970486894, https://openalex.org/W2110792982 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.2147/jaa.s458618 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S164068349 |
| best_oa_location.source.issn | 1178-6965 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1178-6965 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Journal of Asthma and Allergy |
| best_oa_location.source.host_organization | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_name | Dove Medical Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| best_oa_location.source.host_organization_lineage_names | Dove Medical Press |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | https://www.dovepress.com/article/download/94165 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Asthma and Allergy |
| best_oa_location.landing_page_url | https://doi.org/10.2147/jaa.s458618 |
| primary_location.id | doi:10.2147/jaa.s458618 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S164068349 |
| primary_location.source.issn | 1178-6965 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1178-6965 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Journal of Asthma and Allergy |
| primary_location.source.host_organization | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_name | Dove Medical Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320348 |
| primary_location.source.host_organization_lineage_names | Dove Medical Press |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | https://www.dovepress.com/article/download/94165 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Asthma and Allergy |
| primary_location.landing_page_url | https://doi.org/10.2147/jaa.s458618 |
| publication_date | 2024-07-01 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W4233878194, https://openalex.org/W2782770196, https://openalex.org/W2756157332, https://openalex.org/W2593326431, https://openalex.org/W2124647361, https://openalex.org/W2131804486, https://openalex.org/W2051843573, https://openalex.org/W2986706800, https://openalex.org/W2921321215, https://openalex.org/W2582128107, https://openalex.org/W2911447875, https://openalex.org/W2948791597, https://openalex.org/W3023143415, https://openalex.org/W3010261878, https://openalex.org/W2971745569, https://openalex.org/W2807556183, https://openalex.org/W2802043004, https://openalex.org/W4248288734, https://openalex.org/W2595288309, https://openalex.org/W2161775889, https://openalex.org/W2959341277, https://openalex.org/W2810708119, https://openalex.org/W2398652830, https://openalex.org/W2471948536, https://openalex.org/W2746937847, https://openalex.org/W2804882164, https://openalex.org/W3049239500, https://openalex.org/W2050138843, https://openalex.org/W3047292084, https://openalex.org/W2970447247, https://openalex.org/W2548939060, https://openalex.org/W2406482521, https://openalex.org/W2235738899, https://openalex.org/W2897992630, https://openalex.org/W2222292469, https://openalex.org/W2905538201, https://openalex.org/W2041314641, https://openalex.org/W2024465831, https://openalex.org/W2557251223, https://openalex.org/W4223533252, https://openalex.org/W2901610527, https://openalex.org/W2789449717 |
| referenced_works_count | 42 |
| abstract_inverted_index.on | 10 |
| abstract_inverted_index.to | 5, 18 |
| abstract_inverted_index.and | 15 |
| abstract_inverted_index.for | 24 |
| abstract_inverted_index.the | 3 |
| abstract_inverted_index.data | 16 |
| abstract_inverted_index.need | 4 |
| abstract_inverted_index.These | 0 |
| abstract_inverted_index.based | 9 |
| abstract_inverted_index.care. | 26 |
| abstract_inverted_index.asthma | 25 |
| abstract_inverted_index.compare | 7 |
| abstract_inverted_index.develop | 19 |
| abstract_inverted_index.devices | 8 |
| abstract_inverted_index.digital | 21 |
| abstract_inverted_index.several | 11 |
| abstract_inverted_index.findings | 1 |
| abstract_inverted_index.programs | 23 |
| abstract_inverted_index.quality, | 17 |
| abstract_inverted_index.emphasize | 2 |
| abstract_inverted_index.including | 13 |
| abstract_inverted_index.usability | 14 |
| abstract_inverted_index.integrated | 20 |
| abstract_inverted_index.technology | 22 |
| abstract_inverted_index.parameters, | 12 |
| abstract_inverted_index.systematically | 6 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.63765407 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |